ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 164 filers reported holding ACCELERON PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $172,000 | +138.9% | 1,000 | +24.2% | 0.06% | +37.8% |
| Q1 2020 | $72,000 | -75.5% | 805 | -85.5% | 0.04% | -62.2% |
| Q4 2019 | $294,000 | -65.8% | 5,547 | -74.5% | 0.12% | -67.0% |
| Q3 2019 | $859,000 | +17.5% | 21,749 | +22.2% | 0.36% | +17.2% |
| Q2 2019 | $731,000 | -9.8% | 17,800 | +2.3% | 0.31% | -4.6% |
| Q1 2019 | $810,000 | +6.9% | 17,400 | 0.0% | 0.32% | -9.3% |
| Q4 2018 | $758,000 | -19.3% | 17,400 | +6.1% | 0.36% | +16.7% |
| Q3 2018 | $939,000 | +18.0% | 16,400 | 0.0% | 0.30% | +2.3% |
| Q2 2018 | $796,000 | – | 16,400 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |